EZH2 and non-small cell lung carcinoma: We manipulated expression of six recommended genes (MET, WWTR1, EZH2, PTEN, NF1, and KCTD5) in EGFR mutant NSCLC cell lines sensitive to osimertinib (Fig. 5A).